ARTICLE | Company News
Virologic, Triangle HIV deal
September 20, 2001 7:00 AM UTC
VIRS will use VLGC's PhenoSense HIV phenotypic drug resistance assay to assess the efficacy of VIRS's nucleoside reverse transcriptase inhibitors (NRTIs) in treating HIV. ...